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Abstract (words 199/200) 
Background  
To evaluate the impact of respiratory-averaged computed tomography attenuation 
correction (RACTAC) compared to standard single-phase computed tomography 
attenuation correction (CTAC) map, on the quantitative measures of coronary 
atherosclerotic lesions of 18F-sodium fluoride (18F-NaF) uptake in hybrid positron emission 
tomography and computed tomography (PET/CT). 
Methods 
This study comprised 23 patients who underwent 18F-NaF coronary PET in a hybrid 
PET/CT system. All patients had a standard single-phase CTAC obtained during free-
breathing and a 4D cine-CT scan. From the cine-CT acquisition, RACTAC maps were 
obtained by averaging all images acquired over 5 seconds. PET reconstructions using 
either CTAC or RACTAC were compared. The quantitative impact of employing RACTAC 
was assessed using maximum target-to-background (TBRMAX) and coronary 
microcalcification activity (CMA). Statistical differences were analyzed using 
reproducibility coefficients and Bland-Altman plots.   
Results 
In 23 patients, we evaluated 34 coronary lesions using CTAC and RACTAC 
reconstructions. There was good agreement between CTAC and RACTAC for TBRMAX  
(median [Interquartile range]): CTAC= 1.65[1.23-2.38], RACTAC= 1.63[1.23-2.33], 
p=0.55), with coefficient of reproducibility of 0.18, and CMA: CTAC= 0.10 [0-1.0], 




Respiratory-averaged and standard single-phase attenuation correction maps provide 
similar and reproducible methods of quantifying coronary 18F-NaF uptake on PET/CT. 
 
Keywords: Respiration-averaged CT attenuation correction, Motion correction, PET/CT, 
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Abbreviations 
RACTAC respiration-averaged CT attenuation correction 
CTAC  CT attenuation correction  
CMA  coronary microcalcification activity 
18F-NaF 18F-sodium fluoride 
PET  positron emission tomography 
CTA  computed tomography angiography 
ECG-MC cardiac motion corrected 
BC  background blood pool clearance correction 
TBRMAX maximum target to background ratio 
SUVMAX maximum standardized uptake value  









Hybrid positron emission tomography and computed tomography (PET/CT) imaging with 
18F-sodium fluoride (18F-NaF) has been successfully employed for the assessment of 
atherosclerotic disease activity in the coronary arteries and can potentially identify high-
risk plaques (1-4). Currently, hybrid 18F-NaF PET/CT scans are obtained utilizing a 30-
min PET acquisition in listmode format, followed by PET image reconstructions employing 
four or ten cardiac phases with either breath-hold or free-breathing CT attenuation 
correction (CTAC) maps (5-7). Previous studies on myocardial perfusion and viability 
have shown that misalignment of the PET emission data and the CTAC maps pose risks 
of false-positive findings in the clinical setting (8, 9), with loss in the predictive value if not 
corrected for motion (10). To ameliorate this problem, realignment of the CTAC maps and 
PET emission data before PET image reconstruction is sometimes required to obtain 
optimal predictive value (11). However, single-phase CTAC maps affect the quantitative 
accuracy of myocardial viability studies owing to the continuous respiratory translations 
during the PET emission acquisitions(12-15). Previous studies employing respiratory 
averaged CTAC maps (RACTAC), obtained from cine-CT scans can improve the 
quantitative accuracy in myocardial perfusion and viability studies(16, 17). Recently, 18F-
NaF PET has been established as a non-invasive imaging modality to identify high-risk 
and ruptured coronary atherosclerotic plaques(1, 3, 18, 19). Quantitative accuracy and 
reproducibility of imaging this tracer will be critical to establish its clinical value. However, 
the quantitative accuracy of lesion micro-calcification activity assessed with 18F-NaF PET 
and RACTAC for attenuation correction has not yet been evaluated.  
6 
 
In this study, we aimed to evaluate the quantitative impact of using RACTAC on 18F-NaF 
uptake measurements, and to compare RACTAC and CTAC maps for the reconstruction 
of PET images (Figure 1). To this end, we aimed to compare the quantification of 
individual lesions using target-to-background ratios (TBR) and whole-vessel and entire 
coronary tree microcalcification burden using coronary microcalcification activity (CMA) 
assessments (2, 20, 21).  
 
Materials and Methods 
Study population 
Twenty-three patients underwent hybrid 18F-NaF PET/CT examinations of the coronary 
arteries as part of the ongoing Effect of Evolocumab on Coronary Artery Plaque Volume 
and Composition by CCTA and Microcalcification by 18F-NaF PET study 
(NCT03689946)(22). Patient demographics are shown in Table 1. Inclusion in the study 
required a Coronary Computed Tomography Angiography (CCTA) defined high non-
calcified coronary artery plaque volume (>440 mm3). Exclusion criteria were as follows: 
renal dysfunction (serum creatinine > 1.5 mg/dL) prior to imaging, history of allergy to 
iodine contrast agents, allergy to evolocumab, women who are breastfeeding, active atrial 
fibrillation, history of coronary artery bypass graft surgery , inability to lie flat, inability or 
unwilling to give informed consent, major illness or life expectancy <1 year, planned 
coronary revascularization or major non-cardiac surgery in the next 12 months, previous 







The CCTA was acquired the same day as the PET scan for 13 patients, while the 
remaining cases (n=10) had the CCTA within 21 days (range=2-21 days). All patients 
were scanned with arms positioned above the head in a 192-slice Somatom Force Dual 
Source mCT system (Siemens Healthineers, Knoxville, TN, USA). The CCTA imaging 
parameters included prospective gating, 250 ms rotation time, body-mass index (BMI) 
dependent voltage (<25 kg/m2, 100 kV; ≥25 kg/m2, 120 kV), and tube-current time product 
of 160–245 mAs. Patients were administered beta-blockers (orally or intravenously) to 
achieve a target heart rate of <60 beats/min, followed by a BMI-dependent bolus-injection 
of contrast media (400 mg/mL) with a flow of 5–6 mL/s after determining the appropriate 
trigger delay defined by a test bolus of 20 mL of contrast material. 
PET acquisition 
Following the CCTA acquisition (at the same day or different day within a 21 days period 
as described above), all patients underwent 18F-NaF positron emission tomography 
(PET), with arms positioned above the head on a hybrid PET-CT scanner (Discovery 710, 
GE Healthcare, Milwaukee, WI, USA). Prior to imaging, subjects were administered with 
a target dose of 250 MBq of 18F-NaF and rested in a quiet environment for 180 min 
(Figure 2). All patients underwent 30 min PET emission acquisitions, using a standard 3-
lead electrocardiogram using a free-breathing protocol, where the patients were advised 





Cine-CT and standard CT attenuation correction acquisitions.  
Prior to the PET scans, an anteroposterior scout at 100 kV and 10 mA was obtained 
starting from the pulmonary artery bifurcation and extending to the diaphragm. Using the 
anatomical information, 4D cine-CT data were acquired with the following settings: 120 
kV, 10 mA, slice thickness 2.5 mm, 0.8 sec/rotation, axial coverage of 14 cm, 7 cine 
acquisitions, and cine duration of 5 sec. Simultaneously with the cine-CT scan, we 
acquired information on the respiratory signal and its periodicity to perform quality-checks 
on the respiratory averaged CTAC maps using the Varian RPM system (Varian Medical 
Systems). In addition to the cine-CT scan, a standard AC map was acquired at the 
following settings: 100 kV, 40 mA, 0.5 second/rotation, 1.375 pitch factor, 5-mm slice 
thickness with an axial field of view of 15.4 cm, and acquisition time of 1.5 sec.  The total 
radiation doses of 4D cine-CT and standard AC maps were 1.4 mSv and 0.8 mSv, 
respectively.  
 
RACTAC map. From the CINE CT acquisition, we created RACTAC maps from 
averaging the CT images acquired over 5 seconds (Figure 1). To compensate for the 
reduced field-of-view, the RACTAC (axial coverage = 14 cm) was patched with the 
standard CT AC map (axial coverage = 15.4cm) for the missing 1.4 cm. In addition, the 
RACTAC maps were interpolated to obtain the same resolution in the axial direction as 
the standard CTAC map to preserve accurate attenuation correction of the PET images. 
Both the CTAC and the RACTAC maps were used for attenuation correction using a 




PET reconstruction. The acquired electrocardiography-gated raw data (list mode  
dataset) were reconstructed using a standard ordered expectation-maximization 
algorithm with time of flight, and resolution recovery using 4 cardiac bins. All images were 
reconstructed using a 256 × 256 matrix (47 slices) employing 4 iterations and 24 subsets, 
followed by a 5-mm Gaussian post-filtering.  
Two series of PET images, one employing CTAC and another with RACTAC, were 
reconstructed into using a vendor-provided software (REGRECON-REL5, General 
Electric, Wisconsin, USA). 
 
Post reconstruction Cardiac motion correction  Cardiac motion-corrected images 
were obtained from the gated PET reconstructions through PET-PET image co-
registration using a diffeomorphic registration(23). This technique enables alignment of 
all gates to the end-diastolic position and as a result, allows for inclusion of all PET counts 
acquired. We used dedicated coronary PET imaging software for image analysis 
(FusionQuant, Cedars-Sinai Medical Center)(18). 
 
PET quantification  
Background blood pool clearance correction  
To minimize the impact of variations in background blood pool activity introduced by 
variations in the injection-to-scan delays (6), we standardized the background blood pool 
activity to an injection-to-scan delay of 180 minutes using a previously described 
correction factor (6) (Eq. 1) 
SUVBackground corrected = SUVBackground*e(−0.004*(180−t)) (1) 
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where t represents the injection-to-scan delay in minutes. 
 
TBRMAX quantification  
TBRMAX was obtained using a previously described protocol (2). In brief, for individual 
atherosclerotic lesions, the 18F-NaF uptake was evaluated employing maximum 
standardized uptake values (SUVmax) obtained within 3D spherical volumes of interest 
(VOI) (radius 5 mm) placed on the lesions with 18F-NaF focal uptake. TBRMAX values were 
calculated by normalizing the atherosclerotic SUVMAX values by the injection-to-scan 
delay corrected blood pool activity measured in the right atrium (cylindrical volume of 
interest radius 10 mm and thickness 5 mm) at the level of the right coronary artery ostium. 
Lesion SUVmax and TBRmax were evaluated using the same VOIs for both 
reconstructions, using VOIs inserted on PET images reconstructed using CTAC as 
reference.  
 
CMA quantification   
To obtain the CMA(2) values, two distinct steps were performed. First, we selected the 
proximal and distal end of the vessel (>2 mm) and applied a vessel tracking algorithm to 
extract whole-vessel tubular 3D volumes of interest from CCTA using dedicated semi-
automated Autoplaque software (Cedars-Sinai Medical Center, Los Angeles, CA)(24). In 
a tubular VOI, along the extracted centerlines, with 4-mm diameter, we measured the 
coronary microcalcification activity (CMA) on the PET/CT co-registered images. CMA was 
defined as the average SUV within the activity volume above a threshold established as 
the mean background SUV +2 standard deviations. The background activity was 
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measured in the right atrium. In order to evaluate the total uptake, we added the CMA 
activity of all epicardial vessels (CMAtotal).  
 
Offset calculation between CTAC and RACTAC 
Offsets obtained for the two attenuation correction maps were measured in 3D, using the 
aortic valve as a point of reference for the translations observed in the heart. All offsets 
were calculated using the standard CTAC maps as the reference, serving as a gold 
standard for the assessments.  
 
Statistical analysis 
The data were tested for normality using the Shapiro–Wilk test. Statistical analysis was 
performed using MedCalc Statistical Software version 19.1.7 (MedCalc Software bv, 
Ostend, Belgium). Continuous, normally distributed variables were presented as mean 
±SD (standard deviation), whereas non-normally distributed continuous data were 
presented as median [range]. We assessed CMA and TBRMAX, using descriptive statistics 
and Bland–Altman plots, as well as coefficients of reproducibility. Boxplots were designed 
using R 3.5.0 and statistical significance of the difference between the correlated 




Twenty-three patients underwent hybrid 18F-NaF PET/CT examinations of the coronary 
arteries. A total of 34 coronary lesions were identified on reconstructions on both PET 
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corrected with CTAC and RACTAC maps (Figure 3). Across all patients, the median 
(IQR) offset for the CTAC and RACTAC maps were calculated to be 5.4 mm (2.2 mm – 
9.9mm).  
Per-lesion analyses (TBR)  
TBR values obtained using the same delineation of the lesions for reconstructions 
employing CTAC and RACTAC were similar (median TBRmax [Interquartile range; IQR]: 
CTAC = 1.65 [1.23-2.38], RACTAC = 1.63 [1.23-2.33], p =0.55). (Figure 4, A). Good 
agreement of the TBR measures obtained using the two different attenuation correction 
techniques was observed with coefficient of reproducibility of 0.18 (Figure 4, B).   
Per vessel analyses (CMA) 
Assessments of the individual vessel microcalcification burden (CMA) revealed no major 
differences between PET images reconstructed using CTAC and RACTAC scans 
(median [IQR] CMA: CTAC = 0.10 [0-1.0], RACTAC = 0.15 [0-1.03], p=0.19) (Figure 5, 
A). Bland-Altman plots of the CMA values revealed a high degree of agreement when 
comparing the per vessel burden (Figure 5, B), with coefficient of reproducibility of 0.17.  
Coronary tree analyses (CMA) 
Whole-coronary tree microcalcification burden (CMA for all three vessels combined), was 
comparable for the two series of reconstructions (CMAtotal: median [IQR]: CTAC = 1.01 
[0-1.83], RACTAC = 1.05 [0-1.95], p=0.42) (Figure 6, A). In concordance with the single-
vessel CMA burden, the data reconstructed using the two attenuation correction protocols 
were in agreement (Figure 6, B), with a coefficient of reproducibility of 0.17.  
Correlation of lesion activity according to their location  
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Of the 34 coronary lesions, 2 were recognized in the left main stem (LMS), 15 in the left 
anterior descending artery, 8 in the right coronary artery and 9 in the left circumflex artery. 
There was excellent correlation among all lesions (R2=0.97) and there was no difference 




In this study, we evaluated the impact of using standard CTAC maps and RACTAC maps 
obtained from cine-CT maps through respiratory averaging of CT data obtained in 4D on 
coronary PET. Our main finding was that using RACTAC did not introduce any significant 
changes in the quantitative comparisons, both when comparing single lesion activities 
and vessel and the whole coronary tree microcalcification burden. To our knowledge, this 
is the first study evaluating RACTAC maps in the assessment of coronary PET/CT.  
 
Quantitative accuracy is of high importance in the assessment of both the singular 
vulnerable plaque and in the overall assessment of the coronary tree microcalcification 
burden (2). Previous studies have shown that both inter-reader and inter-scan variabilities 
are within acceptable ranges(6, 25). However, the quantitative accuracy can be impaired 
by significant respiratory and patient motion shifts during the acquisition (6, 26). Despite 
improvements in the test-retest reproducibility and reclassification of singular lesions 
following the introduction of sophisticated motion correction techniques, the quantitative 
accuracy might still be impaired by respiratory translations of the PET images during the 
30-min long PET acquisitions. Current attenuation correction protocols employ a single-
phase CT scan (free breathing, or end-expiratory breathing) (5, 12-15). The use of single-
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phase CTAC maps may change the observed uptake patterns in the heart, with deviations 
between 6% in canine models (27), and as much as 35% in human studies (28). In 
addition to the impact of the respiratory averaged CTAC maps, we also need to account 
for potential problems between co-registered PET and CTAC maps which have shown to 
affect myocardial perfusion assessments (8, 9, 11). The impact of misregistration of PET 
emission data and transmission scans (CTAC maps) have not been evaluated in-depth 
yet. However, as many CTAC maps are acquired using free breathing protocols, the 
CTAC maps are likely acquired in an expiratory breathing phase, which is similar to the 
averaged respiratory position during the PET acquisitions. Several efforts to minimize 
potential mismatches have been proposed, hereunder the feasibility of scanning at the 
optimal time during respiration (29-31).  Additionally, the sizes of coronary lesions are 
often of the same magnitude as the PET system resolution, which leaves the attenuation 
correction issues less dominant than partial volume effects. 
 
Unfortunately, even with perfect breath instructions, it is challenging to state the optimal 
breath protocol applicable for all patients and even if the CT scan was obtained at the 
optimal breathing state. Pan et al.(17, 32) demonstrated that potential misalignment 
caused by different breathing phases during helical CT and PET affects both the 
quantitative and qualitative accuracy. By utilizing RACTAC for attenuation correction 
instead of the commonly employed CTAC, the frequency and impact of breathing 
artefacts were reduced, with improved tumor quantification as a result (16). It was argued 
that by utilizing, fast-scan cine CT acquisition of 5 seconds it is possible to bring together 




In this study, we did not observe any significant changes in PET uptake values between 
the reconstructions obtained using CTAC and RACTAC. This finding contrasts with 
previous reports (8, 17, 27), in which up to 40% of the false-positive results normalized 
with the use of respiratory averaged CTAC maps (8). Several reasons could explain this. 
First, the investigators were measuring the activity of the myocardium and because of the 
higher diaphragmatic position at end-expiration they observed more misregistration 
artefacts resulting in decreased emission activity in inferior, inferoseptal, and inferolateral 
walls and compromised quantitative accuracy and the interpretation of myocardial 
viability. These artifacts were corrected by using respiratory-gated average attenuation 
maps. In our study, we concentrated on a focal activity away from the diaphragm and did 
not observe a difference in coronary 18F-NaF uptake between the single-phase CTAC 
and respiratory averaged CTAC. Second, in these studies, the investigators measured 
the average activity, while we measured maximum activity (TBRMAX) or activity above a 
specific threshold (CMA). By measuring maximum activity, we have encountered less 
variability by potential motion-driven misregistration as our volume of interest had a 
diameter of 5 mm. Gould et al.  (8) showed that it was the transaxial misregistration of >6 
mm that frequently caused artefactual defects and therefore by applying a volume of 
interest of 5 mm and measuring maximal activity we encountered less variability in our 
measurements. Third, the median offset of the CTAC and RACTAC images were of 
magnitude of 5.4mm (3D), with only 5 patients having translations of more than 10mm 
between the CTAC and RACTAC maps. These minor offsets combined with the 
averaging of the attenuation correction maps result in a relatively small impact of 
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RACTAC images when compared to the CTAC maps. Finally, we used cardiac motion-
corrected reconstructions(5) improving our ability to discriminate activity coming from the 
corresponding plaque lesion and improving our co-registration. We have previously 
shown that cardiac motion causes attenuation artifact and therefore correcting for cardiac 
motion improves our ability to detect coronary artery disease on myocardial perfusion 
scans (33). Such cardiac motion correction was not used in previous RACTAC work with 
myocardial perfusion scans (34). In particular, the effects of cardiac contraction exceed 
that of respiration with regards to the displacement of the coronaries (cardiac contraction 
displaces the coronary arteries 8–26mm during the cardiac cycle, while normal respiration 
leads to movement of the heart of approximately 6–13mm (35).  
 
The coefficient of reproducibility reported in this study is similar to findings reported in 
test-retest reproducibility studies where both similar interscan variations (6), and inter-
reader variations we observed(25). While these results have focused on the test-retest 
and inter-reader variability for two different studies, our current study reports variations 
occurring as a result of the attenuation correction. The main finding of this study is that 
the variations added to the quantitative assessments of the per-lesion and whole coronary 
tree microcalcification burden are within the range of the reported variations. Therefore, 
RACTAC applied to the coronary plaque assessments does not seem to change the 
quantitative 18F-NaF PET results when compared to the standard CTAC technique.  
 
One concern in terms of employing the cine-CT in the routine clinical assessment is the 
added radiation dose, which conflicts with the as low as reasonably achievable (ALARA) 
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principle. The ALARA principle might be compromised in studies of 18F-NaF studies, as 
we in this study did not find any diagnostic relevant changes in the lesion assessment 
using the RACTAC corrected reconstructions. Based on the calculations, the dose-
burden given to a standard 70kg man equals 9.1mSv. This dose can be divided into the 
dose of the PET emission data (6.7mSv) and corresponding low-dose CTAC map (1mSv) 
and an additional 1.4mSv (15.2% extra dose) obtained for the cine-CT scan. While the 
difference between RACTAC and the regular CTAC is relatively low, the findings of this 
study indicate that the increased dose does not improve the quantification of coronary 




Our study has limitations. First, our sample is small (23 patients). Despite that, we showed 
that our reproducibility coefficient is below the previously reported interobserver and 
interscan variation (25). Second, we report results obtained using cardiac motion 
correction which have less noise and lower TBR values than the commonly presented 
end-diastolic imaging reconstruction (1, 19). However, previous studies from our group 
have shown that both end-diastolic and cardiac motion corrected images can be used for 
18F-NaF coronary uptake assessments (5, 6). Third, a correlation between the volume 
with active microcalcification and the SUVmax or TBR measurements as the volume of 
activity is unknown. This limitation, although of clinical importance, is not affected by the 
attenuation correction, as shown in Figure 7 and, thus, not considered to affect the results 
of this paper. Fourth, it is a single-center study and we used only scanners from one 
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vendor, thus, vendor-specific variations cannot be ruled out. A bigger study involving 
multiple centers and readers would be required to confirm our findings. Finally, the results 
presented in this study apply to the coronary PET imaging only, the effect of using 
RACTAC maps in other studies relying on absolute SUV measurements such as sarcoid 
PET/CT will need to be evaluated in future studies. 
 
New Knowledge Gained 
Using RACTAC instead of CTAC maps does affect quantitative accuracy of 18F-NaF 
PET/CT uptake. This finding is important to ensure the optimal quantitative accuracy in 
studies utilizing 18F-NaF PET with standard CTAC maps, such as in Prediction of 
Recurrent Events With 18F-Fluoride [PREFFIR; NCT02278211] study, where 
investigators use 18F-NaF PET/CT as a marker of coronary plaque vulnerability to detect 
culprit and non-culprit unstable coronary plaques in patients with recent myocardial 
infarctions to determine the prognostic significance of coronary 18F-NaF uptake. Based 
on this finding, given a comparable quantitative accuracy of CTAC and RACTAC maps, 
both approaches can be used depending on the institutional acquisition protocols.  
 
Conclusion 
Applying respiration-averaged CT attenuation correction (RACTAC) maps do not affect 
the quantification of the coronary lesions as read in fusion PET/CT images. Current 
protocols utilizing single-shot CTAC maps provide equivalent corrections for the clinical 
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Age (SD) 66±10 
Sex (Males)  21 (78%) 
BMI (SD) 27±4 
Hyperlipidemia 24 (89%) 
Hypertension 14 (52%) 
Diabetes 5 (18%) 
Smoker/ex-smoker 7 (26%) 
Total Plaque Volume (mm3) 837 [620-1066] 
Total NCP Volume (mm3) 711 [55—859] 
Total Calcified Volume (mm3) 103 [43-205] 
Continuous variables reported as mean ± SD or median [interquartile range]; categorical 
















Standard attenuation map-CTAC (left) vs respiratory average CT attenuation maps-







Imaging protocol for PET acquistion. All patients were scanned with arms positioned 
above the head. 
AP: anteroposterior, CTAC: coronary tomography attenuation correction, PET: positron 





Figure 3  
Left anterior descending artery 18F-NaF uptake. Left panel shows fused CTA and PET 
images reconstructed using the CTAC maps, whereas right shows the same CTA fused 
with PET an image reconstructed using RACTAC. There is good agreement between the 
measurements.  
CTA = computed tomography angiography, CTAC = Computed Tomography Attenuation 






Figure 4  
A) Boxplot with connecting lines between the TBRmax measurements using the 
RACTAC maps vs CTAC maps (blue and red boxes represent interquartile range, with a 
thick solid line inside represents the median), B) Bland-Altman plot of the differences 
between the TBRmax measured using RACTAC maps vs CTAC maps.  
TBRmax = maximum Target to background ratio, CTAC = Computed Tomography 
Attenuation Correction and RACTAC = Respiratory averaged computed tomography 





Figure 5  
A) Boxplot with connecting lines between the CMA measurements using the RACTAC 
maps vs CTAC maps (blue and red boxes represent interquartile range, with thick solid 
line inside represents the median), B) Bland-Altman plot of the differences between the 
CMA measured using RACTAC maps vs CTAC maps.  
CMA = coronary microcalcification activity, CTAC = Computed Tomography Attenuation 
Correction and RACTAC = Respiratory averaged computed tomography attenuation 






 A) Boxplot with connecting lines between the CMA total measurements using the 
RACTAC maps vs CTAC maps (blue and red boxes represent interquartile range, with 
thick solid line inside represents the median), B) Bland-Altman plot of the differences 
between the CMAtotal measured using RACTAC maps vs CTAC maps.  
CMAtotal = whole coronary tree microcalcification activity, CTAC = Computed 
Tomography Attenuation Correction and RACTAC = Respiratory averaged computed 





Figure 7  
Correlation plot of SUVmax across the different lesion location. Excellent correlation (R2) 
shown indendent of the cornary artery involved.  
LMS= left main stem, LAD= left anterior descending artery, RCA= right coronary artery 
and LCx= left circumflex artery, SUVmax= maximum standardized uptake value, CTAC 
= Computed Tomography Attenuation Correction and RACTAC = Respiratory averaged 
computed tomography attenuation correction 
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